PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function, Including Augmented Renal Clearance and End-Stage Renal Disease
Crossref DOI link: https://doi.org/10.1007/s40121-016-0143-9
Published Online: 2016-12-24
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xiao, Alan J.
Caro, Luzelena
Popejoy, Myra W.
Huntington, Jennifer A.
Kullar, Ravina
Funding for this research was provided by:
Merck